Morgan Stanley’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Sell |
|
|||||
|
2025
Q1 | $23.5M | Buy |
|
|||||
|
2024
Q4 | $9.75M | Buy |
|
|||||
|
2024
Q3 | $6.71M | Buy |
|
|||||
|
2024
Q2 | $3.62M | Buy |
|
|||||
|
2024
Q1 | $2.85M | Sell |
|
|||||
|
2023
Q4 | $5.74M | Buy |
|
|||||
|
2023
Q3 | $1.19M | Buy |
|
|||||
|
2023
Q2 | $868K | Buy |
|
|||||
|
2023
Q1 | $252K | Buy |
|
|||||
|
2022
Q4 | $158K | Buy |
|
|||||
|
2022
Q3 | $185K | Sell |
|
|||||
|
2022
Q2 | $195K | Sell |
|
|||||
|
2022
Q1 | $360K | Sell |
|
|||||
|
2021
Q4 | $3.96M | Buy |
|
|||||
|
2021
Q3 | $603K | Buy |
|
|||||
|
2021
Q2 | $602K | Sell |
|
|||||
|
2021
Q1 | $1.43M | Buy |
|
|||||
|
2020
Q4 | $202K | Buy |
|
|||||
|
2020
Q3 | $64K | Sell |
|
|||||
|
2020
Q2 | $114K | Buy |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $315K | Buy |
|
|||||
|
2019
Q3 | $78K | Buy |
|
|||||
|
2019
Q2 | $6K | Sell |
|
|||||
|
2019
Q1 | $534K | Buy |
|
|||||
|
2018
Q4 | $182K | Sell |
|
|||||
|
2018
Q3 | $235K | Buy |
|
|||||
|
2018
Q2 | $13K | Buy |
|